Home › Funds › Alpha Wave Global, LP › LSTA
Alpha Wave Global, LP position in LSTA
LISATA THERAPEUTICS INC · Health Care
Alpha Wave Global, LP reported holding 183,323 shares of LSTA (LISATA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$264K, representing 0.01% of its reported portfolio and ranking #7 among its reported holdings. Alpha Wave Global, LP first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Alpha Wave Global, LP's LSTA position evolved
Alpha Wave Global, LP first disclosed a stake in LSTA in Q3 2026 at 183,323 shares (US$264K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 183.32K | $263.99K | New |
About LSTA and 13F data
LSTA (LISATA THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in LSTA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Alpha Wave Global, LP
FAQ
How long has Alpha Wave Global, LP held LSTA?
Alpha Wave Global, LP has disclosed LSTA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Alpha Wave Global, LP's current position in LSTA?
As of Q3 2026, Alpha Wave Global, LP holds 183.32K shares of LSTA (LISATA THERAPEUTICS INC), valued at $263.99K, representing 0.01% of its reported portfolio and ranking #7.
Has Alpha Wave Global, LP been buying or selling LSTA?
In the latest 13F filing (Q3 2026), Alpha Wave Global, LP newly opened its position in LSTA.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.